Monday, November 2, 2009
Peer Schatz, CEO of Qiagen N.V., says he's not a fan of building companies through acquisition.
But since he took over the helm in 2004, the sample and assay technologies
company has been one of the most active buyers in the space, acquiring 16
companies in the last five years. His point is an acquirer must first have an
underlying capability to innovate, and that acquisitions have to plug into that
In Qiagen's case, Schatz said the
core competency and strategy is in the transformation of raw biology from the
sample processing steps - collection, stabilization, logistics, isolation and
purification - through to the assay, including detection.